| Symbol |
Name |
|
BAK1
|
BCL2-antagonist/killer 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
DCAF7
|
DDB1 and CUL4 associated factor 7
|
|
DIXDC1
|
DIX domain containing 1
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GRIPAP1
|
GRIP1 associated protein 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
IL1B
|
interleukin 1, beta
|
|
JUN
|
jun proto-oncogene
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PRKCD
|
protein kinase C, delta
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
STK10
|
serine/threonine kinase 10
|
|
TP53
|
tumor protein p53
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
